Izervay Patient Assistance Program

(avacincaptad pegol)

Key Takeaways

  1. Izervay® (avacincaptad pegol) is a prescription intravitreal medication used to treat geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
  2. Izervay works by inhibiting complement component C5, helping slow the progression of geographic atrophy and the enlargement of retinal lesions.
  3. Treatment is administered as a once-monthly injection into the eye by an ophthalmologist or other qualified eye care professional.
  4. Prescription Hope may help eligible individuals access manufacturer-sponsored patient assistance programs that can make Izervay more affordable.

 

Introduction

Geographic atrophy (GA) is an advanced form of dry age-related macular degeneration (AMD) that causes the gradual loss of retinal cells responsible for central vision. As the disease progresses, patients may experience increasing difficulty reading, recognizing faces, driving, and performing other everyday activities. While there is currently no cure for geographic atrophy, newer therapies can help slow disease progression.

Izervay is a prescription ophthalmic medication approved to treat geographic atrophy secondary to age-related macular degeneration. By targeting part of the body’s complement immune pathway believed to contribute to retinal damage, Izervay helps slow the enlargement of areas of retinal cell loss. Although the medication cannot restore vision that has already been lost, it may help preserve healthy retinal tissue for a longer period.

However, treatment costs can be high without adequate insurance coverage or financial assistance.

Prescription Hope offers qualified patients assistance services for applying to patient assistance programs.

What Is the Izervay Patient Assistance Program?

Understanding Izervay Prescription Assistance

In their search for help paying for Izervay, some patients may have come across the Izervay patient assistance program. But what is a patient assistance program?

Pharmaceutical manufacturers have come to understand the financial burden that some retail name-brand medications entail for patients. To help struggling Americans, some of these pharmaceutical manufacturers have launched patient assistance programs to help qualified patients receive the name-brand medication they need at a lower cost than the market rate.

The downside is that most patient assistance programs require a lot of time, effort, and extensive paperwork to obtain and manage. This often results in a sense of confusion and frustration for the patient in need of medication.

Prescription Hope can help.

How Expert Advocates Help Make Izervay More Affordable

Personalized Medication Assistance

Prescription Hope’s Izervay enrollment assistance offers qualified patients ophthalmology medication support for a reduced price from the retail cost. Our team of patient advocates is honored to help you through the difficulty of applying for a patient assistance program and keeping up with enrollment long-term. We assist you as prescription assistance specialists who understand the process.

Ongoing Patient Support

Our team of patient advocates helps our qualified patients with enrollment, but they also understand the need for long-term medication assistance. This includes prescription refill support, document updates, yearly renewals, program monitoring, and more.

Izervay Price Comparison

vs

Prescription Hope logo

Estimated Retail Price*

$2,059.18

30-Day Supply

Prescription Hope Price

$70

Per Month, NO Matter The Retail Price

*Source: Drugs.com

Navigating Geographic Atrophy Treatment Costs

Name-brand medications are often very expensive out of pocket.

Prescription Hope offers a different kind of specialty medication support. We are not an insurance company, government-affiliated, or a coupon. We are a medication access service that helps qualified patients get access to the name-brand medication they need for the low cost of $70.00 per month, per medication. This price has no hidden fees, add-ons, or even medication costs.

Patients who do not qualify may still find help through our services. And, if we can’t help you save money, you pay us nothing!

Izervay Patient Assistance Eligibility

General Eligibility Requirements

Those interested in who qualifies for Izervay assistance will need to understand Izervay patient assistance qualifications. Each patient assistance program has its own requirements for approval, so patients can often tell ahead of time if they may qualify.

Programs will usually highlight requirements in a couple of different categories:

Income: All programs have different requirements for what income bracket a patient must be in.

Insurance: All programs also have different requirements for a patient’s insurance status.

Prescription: All patients must have a valid prescription for their intended name-brand medication.

U.S. Residency: Only legal residents of the U.S. can qualify for a patient assistance program.

Simple Enrollment With Expert Support

Getting Started With Enrollment

Are you ready to start the Izervay application process? Do you want to enroll in Izervay assistance? You can enroll with Prescription Hope in 6 easy steps:

  1. Submit Information: Our online form only takes a few minutes to fill out.
  2. Advocate Contact: After we get your enrollment form, a patient advocate will reach out to you in 1-2 business days.
  3. Document Collection: After the prequalification phase, our team will collect any needed documents.
  4. Provider Coordination: Our team will also coordinate with your healthcare providers to obtain any needed signatures.
  5. Program Submission: After everything is gathered and all the paperwork is in order, we will submit your application for a patient assistance program on your behalf and continue to coordinate with the pharmaceutical manufacturer for you.
  6. Medication Delivery: Patients typically receive their medication in the mail in 1-2 weeks after approval.

Prescription Hope is not a pharmaceutical manufacturer or pharmacy, and therefore does not handle medication. All medications are shipped directly from the pharmaceutical manufacturer to the patient’s door or doctor’s office.

Understanding Izervay

How Izervay Works

Izervay is a complement C5 inhibitor that targets part of the body’s complement immune pathway, which is believed to contribute to retinal cell damage in geographic atrophy.

By blocking complement component C5, Izervay reduces the formation of downstream inflammatory mediators and the membrane attack complex (MAC), helping slow the enlargement of areas of retinal cell loss. This may help preserve retinal tissue for a longer period in patients with geographic atrophy secondary to age-related macular degeneration.

Although Izervay slows disease progression, it is not a cure for geographic atrophy and does not restore vision that has already been lost.

What Conditions Does Izervay Treat?

Izervay is FDA-approved for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Geographic atrophy is an advanced form of dry AMD that causes progressive loss of retinal cells and can lead to irreversible central vision loss over time.

Izervay is intended to slow the progression of geographic atrophy by reducing the rate at which retinal lesions enlarge. Regular monthly treatment and ongoing eye examinations are typically necessary to maintain therapeutic benefit.

Benefits of Treatment

For appropriate patients with geographic atrophy secondary to age-related macular degeneration, Izervay offers the first opportunity to help slow the progression of this vision-threatening disease.

Potential treatment benefits include slowing the progression of geographic atrophy, reducing the enlargement of retinal lesions, preserving retinal tissue for a longer period, delaying worsening of vision associated with geographic atrophy, helping maintain functional vision longer than untreated disease, and providing an FDA-approved treatment option for patients with advanced dry age-related macular degeneration.

While Izervay has demonstrated the ability to slow disease progression, it does not reverse existing retinal damage or restore vision that has already been lost.

Important Safety Information and Side Effects

Izervay does not carry an FDA Boxed Warning.

The most commonly reported side effects include conjunctival hemorrhage, increased intraocular pressure, blurred vision, neovascular (“wet”) age-related macular degeneration, punctate keratitis, and eye pain. Patients should notify their healthcare provider if side effects become severe or persistent.

Intravitreal injections, including Izervay, have been associated with endophthalmitis and retinal detachment. To reduce these risks, Izervay should always be administered using proper aseptic injection technique by a qualified eye care professional. Patients should seek immediate medical attention if they experience increasing eye pain, worsening eye redness, sensitivity to light, sudden vision loss, or new floaters.

Temporary increases in intraocular pressure have been observed within minutes following intravitreal injection. Healthcare providers may monitor intraocular pressure and optic nerve perfusion after treatment when clinically appropriate.

Treatment with Izervay may increase the risk of developing neovascular (wet) age-related macular degeneration. Patients should undergo regular ophthalmic monitoring throughout treatment so that any changes can be identified and managed promptly.

Izervay should not be administered to patients with ocular or periocular infections or active intraocular inflammation.

Human data regarding Izervay use during pregnancy are limited. Patients who are pregnant or planning to become pregnant should discuss the potential risks and benefits of treatment with their healthcare provider. It is unknown whether avacincaptad pegol passes into human breast milk. Patients should discuss breastfeeding plans with their healthcare provider before beginning treatment.

Because systemic exposure following intravitreal administration is minimal, clinically significant systemic drug interactions are not expected. However, patients should inform their healthcare provider about all prescription medications, over-the-counter medications, vitamins, and herbal supplements before receiving treatment.

Izervay is administered as an intravitreal injection by an ophthalmologist or other qualified eye care professional. The recommended dosage is 2 mg (0.1 mL) into each affected eye once monthly (approximately every 28 ± 7 days). Each vial is for single-dose use only, and patients should continue regular ophthalmic examinations throughout therapy.

Healthcare providers routinely monitor for endophthalmitis, retinal detachment, increased intraocular pressure, and the development of neovascular (wet) age-related macular degeneration during treatment.

Access to Multiple Medications

Support Beyond Izervay

Some patients looking for retinal disease medication support are looking for multiple medication assistance programs. Prescription Hope offers access to hundreds of brand-name medications and their associated patient assistance programs so that qualified patients can get the specialty medication assistance they need.

Through Prescription Hope, every medication you qualify for is available to you for the same price of $70.00 per month, per medication.

Why Choose Prescription Hope for Izervay Assistance

Patient-Focused Medication Support

Since 2006, Prescription Hope has helped qualified patients across America get the name-brand medications they need at a lower cost than the retail price. We offer prescription affordability support and patient-centered prescription help to Americans from the big cities to the rural countryside.

Simplified Access to Specialty Medications

Prescription Hope charges a service fee of $70.00 per month, per medication. There are no add-ons, hidden charges, or medication costs. If we cannot help you save money, you pay us nothing.

Ongoing Prescription Assistance

Prescription Hope will also help you with all the administrative tasks after your acceptance into a patient assistance program. Some of those tasks include refill scheduling, yearly renewals, document updates, program monitoring, and more.

Network Access

We have a network that spans America, allowing patients access to hundreds of brand-name medications and their associated patient assistance programs.

If you’re looking for help with the Izervay patient assistance program, then enroll with Prescription Hope to see how we can help you save today!

 

Frequently Asked Questions

It's Easy!

Submit Enrollment Form

Getting started is free and easy! Simply complete the online enrollment form. 

Receive Welcome Call

An Enrollment Specialist will reach out to you for a personalized welcome call.

We Manage The Process

Your dedicated team manages your account month after month, allowing you to focus on what matters most—your health.

Helpful Articles

Latest News & Stories

Save Money On Your Prescriptions Today!